206
Views
82
CrossRef citations to date
0
Altmetric
Original Research

Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review

, , , , &
Pages 269-281 | Published online: 23 May 2014

References

  • QuigleyCOpioid switching to improve pain relief and drug tolerabilityCochrane Database Syst Rev20043CD00484715266542
  • GoodheartCRLeavittSBManaging opioid-induced constipation in ambulatory care patientsPain Topics2006 Available from: http://updates.pain-topics.org/pdf/Managing_Opioid-Induced_Constipation.pdfAccessed March 18, 2014
  • LeslieJBellTAnnunziataKFreedmanDOpioid-induced constipation compromises pain management and impacts patient quality of lifeAnesthesiology2006105Abstr1490
  • BellTJPanchalSJMiaskowskiCThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)Pain Med2009101354218721170
  • Penning-van BeestFJvan den HaakPKlokRMPrevooYFvan der PeetDLHeringsRMQuality of life in relation to constipation among opioid usersJ Med Econ201013112913520128662
  • HjalteFBerggrenACBergendahlHHjortsbergCThe direct and indirect costs of opioid-induced constipationJ Pain Symptom Manage201040569670320727708
  • BoswellKKwongWJKavanaghSBurden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature reviewJ Opioid Manag20106426928920862907
  • PanchalSJMuller-SchwefePWurzelmannJIOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInt J Clin Pract20076171181118717488292
  • BrownRTZuelsdorffMFlemingMAdverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant painJ Opioid Manag20062313714617319447
  • CookSFLanzaLZhouXGastrointestinal side effects in chronic opioid users: results from a population-based surveyAliment Pharmacol Ther200827121224123218363893
  • AllanLHaysHJensenNHRandomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer painBMJ200132272951154115811348910
  • PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg2001182Suppl 5A11S18S11755892
  • CandyBJonesLGoodmanMLDrakeRTookmanALaxatives or methylnaltrexone for the management of constipation in palliative care patientsCochrane Database Syst Rev20111CD00344821249653
  • KellyPCookSFKaufmanDWPrevalence and characteristics of opioid use in the US adult populationPain2008138350751318342447
  • FrankLKleinmanLFarupCTaylorLMinerPJrPsychometric validation of a constipation symptom assessment questionnaireScand J Gastroenterol199934987087710522604
  • LowensteinOLeyendeckerPHoppMCombined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExpert Opin Pharmacother200910453154319243306
  • MichnaEBlonskyERSchulmanSSubcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled studyJ Pain201112555456221429809
  • SimpsonKLeyendeckerPHoppMFixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer painCurr Med Res Opin200824123503351219032132
  • SlootsCERykxACoolsMKerstensRDe PauwMEfficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationDig Dis Sci201055102912292120428949
  • MeissnerWLeyendeckerPMueller-LissnerSA randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipationEur J Pain2009131566418762438
  • ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
  • ReillyMCBraccoARicciJFSantoroJStevensTThe validity and accuracy of the Work Productivity and Activity Impairment questionnaire – irritable bowel syndrome version (WPAI: IBS)Aliment Pharmacol Ther200420445946715298641
  • BushnellDMReillyMCGalaniCValidation of electronic data capture of the Irritable Bowel Syndrome – Quality of Life Measure, the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome and the EuroQolValue Health M20069298105
  • ReillyMCMcBurneyCRResponsiveness of the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome with Constipation (WPAI: IBS-C) to clinically meaningful changePoster presented at the annual meeting of the American College of GastroenterologyOctober 30 to November 2, 2005Honolulu, HI, USA
  • RabinROemarMOppeMEQ-5D-3L User Guide: Basic Information on How to Use the EQ-5D-3L InstrumentRotterdam The NetherlandsThe EuroQol Group2011
  • BushnellDMMartinMLRicciJFBraccoAPerformance of the EQ-5D in patients with irritable bowel syndromeValue Health200692909716626412
  • BrazierJRobertsJTsuchiyaABusschbachJA comparison of the EQ-5D and SF-6D across seven patient groupsHealth Econ200413987388415362179
  • ThomasKJMacPhersonHRatcliffeJLonger term clinical and economic benefits of offering acupuncture care to patients with chronic low back painHealth Technol Assess2005932 iii–iv, ix–x1109
  • PleilAMCoyneKSReesePRThe validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue – the BSWValue Health20058Suppl 1S25S3416336486
  • SantosJCTeloERSolifenacin: scientific evidence in the treatment of overactive bladderArch Esp Urol201063319721320431184
  • TutejaAKBiskupiakJStoddardGJLipmanAGOpioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer painNeurogastroenterol Motil2010224424430 e9620100280
  • BraccoAReillyMCMcBurneyCRAmbegaonkarBBurden of irritable bowel syndrome with constipation on healthcare resource utilization, work productivity, activity impairment and quality of life in France, Germany and the United KingdomPaper presented at the 13th United European Gastroenterology WeekOctober 15–20, 2005Copenhagen, Denmark
  • ReimerKHoppMZenzMMeeting the challenges of opioid-induced constipation in chronic pain management – a novel approachPharmacology2009831101718957874
  • FordACBrennerDMSchoenfeldPSEfficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysisAm J Gastroenterol2013108101566157423752879
  • PuhanMAAklEABryantDDiscussing study limitations in reports of biomedical studies- the need for more transparencyHealth Qual Life Outcomes2012102322360847
  • BhinderSChowdhuryNGrantonJFeasibility of internet-based health-related quality of life data collection in a large patient cohortJ Med Internet Res2010123e3520719740
  • KelstrupAMJuilleratPKorzenikJThe accuracy of self-reported medical history: a preliminary analysis of the promise of Internet-based research in inflammatory bowel diseasesJ Crohns Colitis10302013 [Epub ahead of print.]
  • BansbackNTsuchiyaABrazierJAnisACanadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studiesPLoS One201272e3111522328929